APA (7th ed.) Citation

Elzinga, H. B. E., Otten, J. J., Cornet, M. E., Rinia, A. B., Van Der Lans, R. J. L., Fokkens, W. J., . . . Hoven, D. R. (2025). Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease. Allergy, 80(6), 1737. https://doi.org/10.1111/all.16579

Chicago Style (17th ed.) Citation

Elzinga, H. B. E., et al. "Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease." Allergy 80, no. 6 (2025): 1737. https://doi.org/10.1111/all.16579.

MLA (9th ed.) Citation

Elzinga, H. B. E., et al. "Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease." Allergy, vol. 80, no. 6, 2025, p. 1737, https://doi.org/10.1111/all.16579.